Levine Cancer Institute, one of the largest cancer care centers included in the Carolinas HealthCare System, has been designated a center of excellence in the Caris Centers of Excellence for Precision Medicine Network. The nomination was made by the Irving, Texas-based biotech company Caris Life Sciences with the purpose of assuring precision and excellence in medical care.
The nomination is a benchmark of excellency for the Levine Cancer Institute, which receives over 11,000 new cancer patients every year. Its president, Derek Raghavan, MD, PhD, has also been named vice chairman of the Caris Centers of Excellence for Precision Medicine Network, to support the network’s mission to develop tumor profiling standards and research protocols on tumor profiling.
“We are excited to welcome Levine Cancer Institute to the Network. As one of the most well-respected and largest cancer networks in the country, based in a system of 39 hospitals, Levine Cancer Institute brings a wealth of oncology expertise and innovative approaches to personalized medicine,” stated in a press release the network’s chairman, John Marshall, who also serves as chief of Hematology/Oncology at Georgetown Lombardi Comprehensive Cancer Center.
“I am very pleased that we are able to round out the Network leadership team with a broad range of experts at such a rapid pace. The Network is at the forefront of a paradigm shift in oncology and will assume a leadership role in transitioning the promise of precision medicine into a reality,” added Marshall, who is also professor of Medicine and Oncology at Georgetown University School of Medicine.
As a member of the network the Levine Cancer Institute will now be able to participate on the developmental process of the best practices concerning the integration and use of molecular profiling in oncological medical care. In addition, the center is also expected to raise its widespread utilization and patient access to personalized medicine.
Levine Cancer Institute will have the opportunity to benefit from the multiple-technology tumor profiling service of Caris, the Caris Molecular Intelligence, enhancing its precision medicine practice and improving therapeutic options and clinical trial identification, studying the unique characteristics of patients’ tumors. In addition to Raghavan, Edward Kim, MD, the Department Chair of Solid Tumor Oncology at Levine Cancer Institute, will join the Network Steering Committee as well.
“We are excited to join the Caris Centers of Excellence Network effort, whereby collaborating with other large healthcare organizations, we can provide increasingly powerful and timely personalized information to aid physicians in making difficult therapy decisions,” said Raghavan. “The multi-omic approach, equips our physicians with the most up-to-date molecular data for our patients, enhancing therapy selection, clinical trial participation and furthering our understanding of the biology of patient tumors.”